Pyrazolopyridine compounds and uses thereof
US11242343B2 · kind B2 · utility
8Cited by
42References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 2020 |
| Grant date | Feb 8, 2022 |
| Priority date | — |
| Expiry date | Apr 16, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.